# IDH1/2 Mutational Analysis in AML Patients: Diagnosis and Follow-up

> **NCT04242849** · — · COMPLETED · sponsor: **Josep Carreras Leukaemia Research Institute** · enrollment: 354 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04242849
- **Lead sponsor:** Josep Carreras Leukaemia Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-23
- **Primary completion:** 2019-12-27
- **Final completion:** 2020-01-16
- **Target enrollment:** 354 (ACTUAL)
- **Last updated:** 2025-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04242849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04242849, "IDH1/2 Mutational Analysis in AML Patients: Diagnosis and Follow-up". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04242849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*